What is IRadimed?
IRadimed Corporation is a pioneering developer of magnetic resonance imaging (MRI) compatible medical devices. The company distinguishes itself as the sole provider of a non-magnetic intravenous (IV) infusion pump system engineered for safety during MRI procedures. This patented MRidium® system utilizes a non-magnetic ultrasonic motor and specialized non-ferrous components to ensure predictable and safe delivery of anesthesia and IV fluids during scans. This innovation is critical for maintaining the care of critically-ill patients and sedated children and infants who require continuous monitoring and fluid management during MRI examinations, addressing a significant safety gap in current medical practices.
How much funding has IRadimed raised?
IRadimed has raised a total of $12.6M across 1 funding round:
Stock Offering
$12.6M
Stock Issuance/Offering (2014): $12.6M, investors not publicly disclosed
What's next for IRadimed?
The substantial enterprise-level funding and recent strategic investment indicate IRadimed is poised for significant scaling and market expansion. This capital infusion will likely fuel further research and development into advanced MRI-compatible technologies, enhance manufacturing capabilities, and broaden the company's global commercial reach. The focus on specialized, high-stakes medical devices suggests a strategic direction towards solidifying its leadership position and potentially exploring new applications for its core technology in diagnostic imaging environments.
See full IRadimed company page
